trial · primary record
BGB-B2033
Hepatocellular Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2029-09-30 |
| Primary endpoint | Overall Response Assessment (ORR) by Independent Review Committee Assessment |
| Registry ID | NCT07911683 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:50.349Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07911683
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.